» Articles » PMID: 37367991

Cortical High-flow Sign on Arterial Spin Labeling: a Novel Biomarker for IDH-mutation and 1p/19q-codeletion Status in Diffuse Gliomas Without Intense Contrast Enhancement

Overview
Journal Neuroradiology
Specialties Neurology
Radiology
Date 2023 Jun 27
PMID 37367991
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to investigate whether arterial spin labeling (ASL) features allow differentiation of oligodendroglioma, IDH-mutant and 1p/19q-codeleted (IDHm-codel) from diffuse glioma with IDH-wildtype (IDHw) or astrocytoma, IDH-mutant (IDHm-noncodel). Participants comprised 71 adult patients with pathologically confirmed diffuse glioma, classified as IDHw, IDHm-noncodel, or IDHm-codel. Subtraction images were generated from paired-control/label images on ASL and used to assess the presence of a cortical high-flow sign. The cortical high-flow sign was defined as increased ASL signal intensity within the tumor-affecting cerebral cortex compared with normal-appearing cortex. Regions without contrast enhancement on conventional MR imaging were targeted. The frequency of the cortical high-flow sign on ASL was compared among IDHw, IDHm-noncodel, and IDHm-codel. As a result, the frequency of the cortical high-flow sign was significantly higher for IDHm-codel than for IDHw or IDHm-noncodel. In conclusion, the cortical high-flow sign could represent a hallmark of oligodendroglioma, IDH-mutant, and 1p/19q-codeleted without intense contrast enhancement.

Citing Articles

The cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular density.

Yamashita K, Murayama R, Itoyama M, Kikuchi K, Kusunoki M, Kuga D Neuroradiology. 2025; 67(2):291-298.

PMID: 39831960 DOI: 10.1007/s00234-024-03538-1.


The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods.

Yamashita K, Togao O, Kikuchi K, Kuga D, Sangatsuda Y, Fujioka Y Neuroradiology. 2023; 66(2):187-192.

PMID: 38127124 DOI: 10.1007/s00234-023-03267-x.

References
1.
Koeller K, Rushing E . From the archives of the AFIP: Oligodendroglioma and its variants: radiologic-pathologic correlation. Radiographics. 2005; 25(6):1669-88. DOI: 10.1148/rg.256055137. View

2.
Smits M . Imaging of oligodendroglioma. Br J Radiol. 2016; 89(1060):20150857. PMC: 4846213. DOI: 10.1259/bjr.20150857. View

3.
Latysheva A, Emblem K, Brandal P, Vik-Mo E, Pahnke J, Roysland K . Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach. Neuroradiology. 2019; 61(5):545-555. DOI: 10.1007/s00234-019-02173-5. View

4.
Noguchi T, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Nagao E . Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol. 2008; 29(4):688-93. PMC: 7978189. DOI: 10.3174/ajnr.A0903. View

5.
Togao O, Hiwatashi A, Yamashita K, Kikuchi K, Keupp J, Yoshimoto K . Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging. Eur Radiol. 2016; 27(2):578-588. DOI: 10.1007/s00330-016-4328-0. View